Real-time enrollment status for this biliary tract cancer clinical trial
Current Status
Active, Not Recruiting
Checked: June 1, 2026 at 9:12 PM UTC
| NCT Number | NCT03482102 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Biliary Tract Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 70 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Massachusetts General Hospital |
| Last Updated on CT.gov | May 4, 2026 (4 weeks ago) |
As of June 1, 2026: Clinical trial NCT03482102 is currently active_not_recruiting participants. This clinical trial study for biliary tract cancer is not currently accepting new participants at 2 locations across the United States. The study is sponsored by Massachusetts General Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT03482102 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03482102 was last updated 4 weeks ago (May 4, 2026). HelloStudys verifies this status automatically.